Home › Compare › VTMTF vs ABBV
VTMTF yields 3.29% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, VTMTF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VTMTF + ABBV for your $10,000?
Vertu Motors plc operates as an automotive retailer in the United Kingdom. The company sells new and used cars and motorcycles, motability cars, and commercial vehicles, as well as provides related aftersales services. It operates 150 chain of franchised dealerships offering sales, service, parts, and bodyshop facilities for new and used cars, and commercial vehicles under the Bristol Street Motors, Macklin Motors, and Vertu Motors. The company's franchise dealerships include Audi, BMW, Honda, Jaguar, jeep, Kia, Land Rover, Mercedes-Benz, Mercedes-AMG, MINI, smart, Toyota, Volkswagen, Citroen, CUPRA, Dacia, DS, Ford, Hyundai, Mazda, MG, Nissan, Peugeot, Renault, SEAT, SKÖDA, and Vauxhall. In addition, it operates as a pension scheme trustee; and provides vehicle financing and related insurance products. Further, the company is involved in the online van and parts retailing; and online advertising businesses. It operates through a network of 160 sales and aftersales outlets in 121 locations. Vertu Motors plc was incorporated in 2006 and is headquartered in Gateshead, the United Kingdom.
Full VTMTF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.